Posts Tagged ‘innovation’

Fame is fleeting. Just a few years ago, fake meat was a hot item with great prospects for transforming the future of food. In 2019 in the New York Times, Timothy Egan wrote “Fake Meat Will Save Us.” Other experts suggested burgers were headed for extinction. No wonder the capitalization of Beyond Meat soared to […]

A pair of reports on Monday raised the possibility that we may soon have oral obesity meds that match the remarkable effectiveness of injections. One of these drugs is an oral formulation of semaglutide that’s already available at a much lower oral dose for diabetes under the brand name of Rybelsus. Novo Nordisk makes it. […]

ECO2023 closed today with a clear focus on future progress in obesity. Lee Kaplan offered a view of what that future might look like with a focus on access and delivery of chronic care for obesity. Kaplan told us the future of obesity care lies in getting beyond merely saying that obesity is a disease. […]

We’re headed to Dublin this week for the European Congress on Obesity – ECO2023. At a pace that will surely be overwhelming, we expect to encounter some of the world’s best researchers, clinicians, and patient advocates bringing us new insights. This comes at an exciting time for the field because advanced treatment options are causing […]

With all the sensational reporting about semaglutide and tirzepatide for obesity – often with the emphasis on weight loss – you might think a revolution is underway. Yes, it is coming. But the truth is that it hasn’t even started yet. At present, for a number of reasons, we are barely scratching the surface of […]

Nope. We are not done with fighting obesity by selling water, fruits, and veggies. Former First Lady Michelle Obama is starting a healthy food and beverage company with the help of private equity. Ordinarily, we’re supposed to think of private equity as the bad guys – helping the rich get richer and driving wider disparities. […]

How can we possibly afford paying for all of the innovation that’s coming in obesity care? This is hardly an academic question. It’s a practical one that flickers in the minds of policymakers who balk at finding ways to make effective treatment for obesity more accessible to the people with great medical needs for it. […]

Translating the stunning advances we’re presently seeing in obesity into something that both patients and professionals can appreciate is no small feat. But this is what just happened over the weekend at the Obesity Action Coalition YWM Virtual conference. A planning team led by Bob Kushner and Scott Kahan assembled a small faculty of some […]

Tirzepatide, marketed by Lilly under the  Mounjaro brand, may be gliding toward an FDA approval for obesity later this year. A year ago, the first phase 3 study results for tirzepatide in obesity wowed us. Yesterday, Lilly revealed yet another impressive piece of the puzzle – impressive weight reduction in persons who have both obesity […]

While Ozempic and Wegovy – two injectable forms of semaglutide – have been grabbing headlines, an oral tablet form – Rybelsus – has been quietly building momentum. Right now, it’s only approved for use in type 2 diabetes. But on Friday, Novo Nordisk announced results from the first phase 3 study of oral semaglutide for […]